HMGB1 and neoplasm: This study has shown that cancer-associated fibroblast substances can activate HMGB1 expression and secretion by cancer cells, which can then be released into the tumor microenvironment and the HMGB1-RAGE interaction promotes breast cancer progression and drug resistance [3].